Position in NUVB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,066,196
+$763,650 QoQ
Shares Held
363,767
+19.8% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 242 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. NUVB ranks #154 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in NUVB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,066,196 | 363,767 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,302,546 | 303,624 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $24,268,634 | 2,708,553 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,052,442 | 284,444 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $540,774 | 277,320 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $408,004 | 231,821 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $598,566 | 225,025 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $492,961 | 215,267 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $643,331 | 220,319 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,930,860 | 1,354,632 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $313,835 | 207,838 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $1,061,160 | 791,911 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,450,474 | 805,819 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,418,746 | 854,667 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,679,686 | 874,837 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,041,833 | 911,533 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $275,746 | 85,107 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $265,388 | 50,454 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $316,557 | 37,242 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $139,915 | 14,076 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $106,906 | 11,483 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||